Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report

Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report

Dermatomyositis (DM) positive for anti-melanoma differentiation-associated gene 5 (MDA5) antibodies, mainly when linked with rapidly progressive interstitial lung disease (RP-ILD), is considered a refractory disease. Our report describes a critical case of clinically amyopathic dermatomyositis (CADM...

Full description

Saved in:
Bibliographic Details
Main Authors: Gui-Chen Ling, Chang Su, Ying-Ao Guo, Xia Qiu, Jia-Wei Liu, Min Xiao, Yu-Ya Xiao, Shuo Yang, Jian-Yong Zhang, Jing-Jing Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-10-01
Series:Frontiers in Pharmacology
Subjects:
anti-MDA5-associated dermatomyositis
case report
rapidly progressive interstitial lung disease
mycophenolate mofetil
clinically amyopathic dermatomyositis (CADM)
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1472667/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1472667/full

Similar Items